The Septic Patient: Future Directions
Author:
Gallagher T. James
Reference27 articles.
1. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med, 1992;20:864–874.
2. The Veterans Administration Systemic Sepsis Cooperative Study Group. Effect of high dose glucocorticoid therapy on mortality in patients with clinical signs of systemic sepsis. N Engl J Med, 1987;317:659–665.
3. Meyrick B: Pathology of the adult respiratory distress syndrome. Crit Care Clinics, 1986;2:405–428.
4. Brigham KL, Woolverton WC, Blake LH, et al: Increased sheep lung vascular permeability caused by Pseudomonas bacteria. J Clin Investigation, 1974;54:792.
5. Suffredini AF, Fromm RE, Parker, MM, et al: The cardiovascular response of normal humans to the administration of endotoxin. N Engl J Med, 1989;321:280–287.